Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
crispr
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
alphabet
andrew oxtoby
babies
bio-repository
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
broad institute of harvard and mit
brook byers
ceo
charles chu
clinical hold
clinical study
column
combination
commissioner
congress
crispr cas14
crispr-cas9
deals
decheng capital
delisting
democrats
departure
detroit blog main
detroit top stories
What
big
3
×
bio
3
×
cas
ceo
crispr
medicine
today
according
akin
available
based
biggest
biosciences
blood
bosley's
bosley’s
bridge
bucks
cheaper
company
create
crime
crowdsourced
departure
develop
diagnostics
disruptive
diverse
editas
exit
expects
fact
faster
founder
guiding
internet
katrine
mammoth
medical
moves
Language
unset
Current search:
bio
×
big
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@techcrunch.com
7 years ago
Regenerative medicine today is like the internet in 1993